Diagnostic Utility of Pleural Fluid T-SPOT and Interferon-gamma for Tuberculous Pleurisy: A Two-Center Prospective Cohort Study in China

Tuberculosis (TB) remains the leading cause of death from a curable infectious disease, with an estimated 1.5 million deaths in 2018 (World Health Organization, 2019). Extrapulmonary tuberculosis (EPTB) accounted for 14% of the 6.4 million incident cases (World Health Organization, 2019). Tuberculous pleurisy (TP) is ranked as the second most frequent form of EPTB (Light, 2010; Mehta et al., 1991). China has reported a high than average proportion of TP, dominated by pleural fluid (PF) (Pang et al., 2019).

Source: International Journal of Infectious Diseases - August 5, 2020 Category: Infectious Diseases Authors: Ying Luo, Feng Yan, Ying Xue, Liyan Mao, Qun Lin, Guoxing Tang, Huijuan Song, Shiji Wu, Renren Ouyang, Xu Yuan, Weiyong Liu, Jing Yu, Yu Zhou, Hongyan Hou, Xuejuan Sun, Feng Wang, Ziyong Sun Source Type: research